HOME >> BIOLOGY >> NEWS
International Conference on Emerging Infectious Diseases

Journalists are invited to attend and cover the 2004 International Conference on Emerging Infectious Diseases (ICEID), to be held February 29 to March 3, 2004 at the Atlanta Marriott Marquis Hotel in Atlanta, Georgia. The meeting is being organized by the Centers for Disease Control and Prevention (CDC), the American Society for Microbiology, the Council of State and Territorial Epidemiologists, the Association of Public Health Laboratories and the World Health Organization.

The emergence of infectious diseases is constantly challenging medical science. In the past year a new disease, severe acute respiratory syndrome (SARS), caused what could be characterized as the first pandemic of the 21st century. A particularly virulent and deadly strain of influenza led to unexpected demand and shortages in influenza vaccine in the United States. Antibiotics continue to be less effective against many bacterial infections, while many drug companies are scaling back or abandoning anti-infective research.

The ICEID program will include plenary sessions and symposia with invited speakers, presentations on emerging infections and poster presentations. Topics include lessons learned from SARS outbreak of 2003, the continued spread of antibiotic resistance, the challenges involved in predicting and preventing pandemic influenza, the rise of HIV in the southern United States, bioterrorism preparedness, forensic technology in tracking biocrimes, biosecurity in research laboratories and West Nile virus. The conference will begin with an opening session featuring CDC Director Julie Gerberding at 5:00 p.m. on Sunday, February 29 and conclude at noon on Wednesday, March 3.

Of Special Note: Directly preceding the conference the National Center for Infectious Diseases of the CDC will hold an International Conference on Women and Infectious Diseases: From Science to Action, February 27-28, 2004 at the Atlanta Marriott Marquis. The conference will consist of several
'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
7-Jan-2004


Page: 1 2

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. USAID, Conservation International & Starbucks launch Conservation Coffee Alliance in Central America
3. ConocoPhillips & Conservation International launch Biodiversity Action Plan in Venezuela
4. A room with a view for the International Space Station: Completion of the cupola observation module
5. International symposium on nutritional genomics
6. First International Scientific Conference on Childhood Leukaemia
7. 1st International Conference on Cell Therapy for Cardiovascular Disease
8. International research conferences at the Villa Vigoni
9. Conservation International & SC Johnson invest in Ecuadors rainforest to offset climate impacts
10. STN International launches Derwent World Patents Index First View
11. Media invited to attend International Society For Heart & Lung Transplantation meeting April 21-24

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: International Conference Emerging Infectious Diseases

(Date:5/21/2013)... Mass. , May 21, 2013 Royal ... CX50 xMATRIX, the world,s first portable ultrasound with Philips, ... Echo (ICE) capability. The CX50 xMATRIX with available Live ... Paris at the EuroPCR, official meeting ... May 21-24. Since its launch in 2012, ...
(Date:5/21/2013)... alter the way genes function without changing the ... the blood of pregnant women during any trimester, ... in the weeks after giving birth, and an ... The findings of the small study involving 52 ... Molecular Psychiatry . , "Postpartum depression can ...
(Date:5/20/2013)... resistant to the antibiotic colistin are also commonly ... body, according to a study in mBio ... Society for Microbiology. Cross-resistance to colistin and host ... body against bacterial attack, could mean that patients ... with a crippled immune response. Colistin is a ...
Breaking Biology News(10 mins):Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
(Date:5/21/2013)... 2013 Clinverse, Inc. , ... clinical trials, announced today it has formed a ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates data ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship ... and reporting transfer of value at investigator meetings ...
(Date:5/21/2013)... Smarter Security, Inc., provider of premium, innovative entrance ... a Sanofi company and leading biotech company, recently ordered ... multi-use facility in the United States. With Door Detective ... latest order underscores the satisfaction and success the company ... improving doorway access control. , “We recommend Door ...
(Date:5/21/2013)... According to a new market ... "Biochip Products and Services Market (Microarrays, Reagents, Drug Discovery, ... Share, Growth, Trends and Forecast, 2012 - 2018," the market was valued ... to grow at a CAGR of 10.1% from 2012 ... 4.7 billion in 2018. Browse the full ...
(Date:5/21/2013)... 21, 2013 As the R&D ... push within the industry to deliver better products, ... and pharma companies often means turning big ideas ... developed in collaboration with Sensidose AB and Recipharm, ... bring products to market sooner. The partnership resulted ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 2Door Security at Genzyme, a Sanofi Company, Enhanced with Door Detective from Smarter Security 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
Cached News: